Expression of bovine interleukin-1β in a bovine herpesvirus-1 vector: In vitro analysis

Virology

Volumn 221, Issue 1, 1996, Pages 78-86

  Raggo, Camilo ^c   Fitzpatrick, David R ^a   Babiuk, Lorne A ^c   Liang, Xiaoping ^b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BOVINE HERPES VIRUS; CELL LINE; DELETION MUTANT; GENE LOCUS; GENETIC RECOMBINATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINANT;

EID: 0030198537     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0354     Document Type: Article

References (41)

1. Babiuk, L. A., Wardley, R. C., and Rouse, B. T. (1975). Defense mechanisms against bovine herpesvirus: Relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect. Immun. 12, 958-963.
2. Black, R., Kronheim, S., and Sleath, P. (1989). Activation of interleukin-1 beta by a co-induced protease. FEBS Lett. 247, 386-390.
3. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van-Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A., Huebner, K., and Black, R. A. (1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science 256, 97-100.
4. Chu, G., Hayakawa, H., and Berg, P. (1987). Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 15, 1311-1326.
5. Dinarello, C. A. (1991). Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
6. Gao, Y., Daley, M. J., and Splitter, G. A. (1995). BHV-1 glycoprotein 1 and recombinant interleukin 1β efficiently elicit mucosal IgA response. Vaccine 13, 871-877.
7. Godson, D. L., Baca-Estrada, M. E., Van Kessel, A. G., Hughes, H. P. A., Morsy, M. A., Van Donkersgoed, J., Harland, R. J., Shuster, D. E., Daley, M. J., and Babiuk, L. A. (1995). Regulation of Bovine Acute Phase response by recombinant interleukin-1β. Can. J. Vet. Res. 59, 249-255.
8. Haworth, C., and Feldman, M. (1991). Applications of cytokines in human Immunotherapy. In "The Cytokine Handbook" (A. Thomson, Ed.), pp. 301-304. Academic Press, New York, NY.
9. Hazuda, D. J., Lee, J. C., and Young, P. R. (1988). The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J. Biol. Chem. 263, 8473-8479.
10. Heath, A. W., and Playfair, J. H. (1992). Cytokines as immunological adjuvants. Vaccine 10, 427-434.
11. Howard, A. D., Palyha, O. C., Griffin, P. R., Peterson, E. P., Lenny, A. B., Ding, G. J., Pickup, D. J., Thornberry, N. A., Schmidt, J. A., and Tocci, M. J. (1995). Human IL-1 beta processing and secretion in recombinant baculovirus-infected Sf9 cells is blocked by the cowpox virus serpin crmA. J. Immunol. 154, 2321-2332.
12. Hughes, H. P., Campos, M., van Drunen Littel-van den Hurk, S., Zamb, T., Sordillo, L. M., Godson, D., and Babiuk, L. A. (1992). Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV. Vaccine 10, 226-230.
13. Johnson, D. C., McDermott, M. R., Chrisp, C., and Glorioso, J. C. (1986). Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C. J. Virol. 58, 36-42.
14. Kaashoek, M. J., Moerman, A., Madic, J., Rijsewijk, F. A. M., Quak, J., Gielkens, A. L. J., and van Oirschot, J. T. (1994). A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12, 439-444.
15. Kaye, J., Porcelli, S., Tite, J., Jones, B., and Janeway, C., Jr. (1983). Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J. Exp. Med. 158, 836-856.
16. Kit, S., Qavi, H., Gaines, J. D., Billingsley, P., and McConnell, S. (1985). Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch. Virol. 86, 63-83.
17. Kostura, M. J., Tocci, M. J., Limjuco, G., Chin, J., Cameron, P., Hillman, A. G., Chartrain, N. A., and Schmidt, J. A. (1989). Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc. Natl. Acad. Sci. USA 86, 5227-5231.
18. Kowalski, J., and Denhardt, D. T. (1989). Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytes. Mol. Cell. Biol. 9, 1946-1957.
19. Leong, S. R., Flaggs, G. M., Lawman, M., and Gray, P. W. (1988). The nucleotide sequence for the cDNA of bovine interleukin-1 beta. Nucleic Acids Res. 16, 9054.
20. Liang, X. P., Babiuk, L. A., van Drunen Littel-van den Hurk, S., Fitzpatrick, D. R., and Zamb, T. J. (1991). Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J. Virol. 65, 1124-1132.
21. Liang, X., Babiuk, L. A., and Zamb, T. J. (1992). An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: Evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology 189, 629-639.
22. Liang, X., Tang, M., Zamb, T. J., Babiuk, L. A., Kowalski, J., and Tykocinski, M. L. (1993). Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor. J. Virol. 67, 4896-4904.
23. Maliszewski, C. R., Baker, P. E., Schoenborn, M. A., Davis, B. S., Cosman, D., Gillis, S., and Cerretti, D. P. (1988). Cloning, sequence and expression of bovine interleukin 1 alpha and interleukin 1 beta complementary DNAs. Mol. Immunol. 25, 429-437.
24. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982). "Molecular Cloning: A Laboratory Manual." Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Mayfield, J. E., Good, P. J., VanOort, H. J., Campbell, A. R., and Reed, D. E. (1983). Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper strain). J. Virol. 47, 259-264.
26. Orencole, S. F., and Dinarello, C. A. (1989). Characterization of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. Cytokine 1, 14-22.
27. Pardoll, D. M. (1995). Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13, 399-415.
28. Powrie, F., and Coffman, R. L. (1993). Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14, 270-274.
29. Ramshaw, I. A., Ruby, J., and Ramsay, A. (1992). Cytokine expression by recombinant viruses - A new vaccine strategy. Trends Biotechnol. 10, 424-426.
30. Reddy, D. N., Reddy, P. G., Minocha, H. C., Fenwick, B. W., Baker, P. E., Davis, W. C., and Blecha, F. (1990). Adjuvanticity of recombinant bovine interleukin-1 beta: Influence on immunity, infection, and latency in a bovine herpesvirus-1 infection. Lymphokine Res. 9, 295-307.
31. Reddy, D. N., Reddy, P. G., Xue, W., Minocha, H. C., Daley, M. J., and Blecha, F. (1993). Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2. Vet. Immunol. Immunopathol. 37, 25-38.
32. Seal, B. S., Whetstone, C. A., Zamb, T. J., Bello, L. J., and Lawrence, W. C. (1992). Relationship of bovine herpesvirus 1 immediate-early, early, and late gene expression to host cellular gene transcription. Virology 188, 152-159.
33. Sieling, P. A., and Modlin, R. L. (1994). Cytokine patterns at the site of mycobacterial infection. Immunobiology 191, 378-387.
34. Southern, P. J., and Berg, P. (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-341.
35. Summers, M. D., and Smith, G. E. (1987). A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Texas Agricultural Experimental Station Bulletin 1555.
36. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A., and Tocci, M. J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774.
37. van Drunen Littel-van den Hurk, S., van den Hurk, J. V., Gilchrist, J. E., Misra, V., and Babiuk, L. A. (1984). Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135, 466-479.
38. van Drunen Littel-van den Hurk, S., Tikoo, S. K., Liang, X., and Babiuk, L. A. (1993). Bovine herpesvirus-1 vaccines. Immunol. Cell. Biol. 71, 405-420.
39. van Oirschot, J. T. (1994). Vaccination in food animal populations. Vaccine 12, 415-418.
40. Wyler, R., Engels, M., and Schwyzer, M. (1989). Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). In "Herpesvirus Diseases of Cattle, Horses and Pigs. Developments in Veterinary Virology" (G. Wittman, Ed.), pp. 1-72. Kluwer Academic, Boston.
41. Yates, W. D. (1982). A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46, 225-263.